13F HOLDINGS REPORT
Lynx1 Capital Management LP
Quarter ended Q4 2023 · Filed November 14, 2023 · Accession 0001892688-23-000091
Total Value
$151.2M
Positions
18
Other Managers
1
Confidential Omitted
No
Holdings (18)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | CABALETTA BIO INC | CABA | 2,106,000 | $32.1M | 21.20% |
| 2 | ALPINE IMMUNE SCIENCES INC | 02083G100 | 2,404,614 | $27.5M | 18.21% |
| 3 | MERUS N V | N5749R100 | 1,150,225 | $27.1M | 17.94% |
| 4 | CYMABAY THERAPEUTICS INC | 23257D103 | 994,161 | $14.8M | 9.80% |
| 5 | TSCAN THERAPEUTICS INC | TCRX | 5,224,600 | $13.4M | 8.85% |
| 6 | GH RESEARCH PLC | GHRS | 1,103,178 | $11.1M | 7.33% |
| 7 | STOKE THERAPEUTICS INC | STOK | 1,710,154 | $6.7M | 4.46% |
| 8 | AUTOLUS THERAPEUTICS PLC | AUTL | 1,363,025 | $3.2M | 2.10% |
| 9 | PIERIS PHARMACEUTICALS INC | 720795103 | 9,775,849 | $2.9M | 1.93% |
| 10 | KINNATE BIOPHARMA INC | 49705R105 | 1,997,006 | $2.8M | 1.85% |
| 11 | SILENCE THERAPEUTICS PLC | SLNCF | 235,787 | $2.3M | 1.53% |
| 12 | BIONOMICS LIMITED | 09063M205 | 815,512 | $2.2M | 1.46% |
| 13 | C4 THERAPEUTICS INC | CCCC | 1,019,230 | $1.9M | 1.25% |
| 14 | THESEUS PHARMACEUTICALS INC | 88369M101 | 702,415 | $1.9M | 1.25% |
| 15 | NEKTAR THERAPEUTICS | NKTR | 1,766,815 | $1.1M | 0.70% |
| 16 | PASSAGE BIO INC | PASG | 190,124 | $125,102 | 0.08% |
| 17 | ZURA BIO LTD | ZURA | 9,917 | $65,452 | 0.04% |
| 18 | DBV TECHNOLOGIES S A | DBVTF | 18,265 | $24,840 | 0.02% |